Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2012; 18(13): 1517-1524
Published online Apr 7, 2012. doi: 10.3748/wjg.v18.i13.1517
Published online Apr 7, 2012. doi: 10.3748/wjg.v18.i13.1517
Figure 3 Change in dysmotility-like dyspepsia symptom score over time according to Helicobacter pylori status.
Significantly greater symptomatic improvement was seen in the proton pump inhibitor group than in the H2-receptor antagonist (H2RA) + prokinetic (Prok) group after 28 d of treatment, regardless of Helicobacter pylori (H. pylori) status. No additional significant symptomatic improvement was seen after day 7 of H2RA + Prok treatment, regardless of H. pylori status. aP < 0.05, PPI vs H2RA + Prok; cP < 0.05 vs pre-Rx in each group; eP < 0.05 vs 7 d Rx in each group.
- Citation: Sakaguchi M, Takao M, Ohyama Y, Oka H, Yamashita H, Fukuchi T, Ashida K, Murotani M, Murotani M, Majima K, Morikawa H, Hashimoto T, Kiyota K, Esaki H, Amemoto K, Isowa G, Takao F. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. World J Gastroenterol 2012; 18(13): 1517-1524
- URL: https://www.wjgnet.com/1007-9327/full/v18/i13/1517.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i13.1517